News & Opinion

News

Quick Hits: New Breast Cancer Drugs Have Fewer Side Effects, Antidepressant Use in Pregnancy and Autism & More

July 20, 2017
Quick Hits: New Breast Cancer Drugs Have Fewer Side Effects, Antidepressant Use in Pregnancy and Autism & More

CDK inhibitors appear to be less toxic than previous breast cancer treatments and autism risk slightly higher in children born to moms that took antidepressants.

Surgery For Early-Stage Prostate Cancer May Not Prolong Life

July 19, 2017
Surgery For Early-Stage Prostate Cancer May Not Prolong Life

Surgery for early-stage prostate cancer hardly improves a man’s lifespan compared to just monitoring the cancer, though the procedure can lead to long-term side effects.

Seniors on Many Meds More Likely to Have Falls

July 18, 2017
Seniors on Many Meds More Likely to Have Falls

Seniors taking 5 or more medications are more prone to experience falls and walk more slowly.

Panel Urges FDA to Change How It Evaluates Opioids

July 17, 2017

A new “action plan” proposed by an independent panel calls on the FDA to review the safety and effectiveness of current opioids and re-examine new opioids every few years after approval.

Quick Hits: Withdrawn Leukemia Drug May Return to Market, Device Makers Get Break on Reporting Malfunctions & More

July 13, 2017
Quick Hits: New Breast Cancer Drugs Have Fewer Side Effects, Antidepressant Use in Pregnancy and Autism & More

A leukemia drug pulled from the market over questions about efficacy and toxicity may be returning to market and legislation would allow device makers to delay reporting malfunctions.

Medication Errors Making People Ill Skyrocket

July 12, 2017
Medication Errors Making People Ill Skyrocket

A dramatic rise in prescribing of cardiovascular drugs, painkillers and insulin may be a key reason why unintentional medication errors are growing.

FDA Chief Wants Doctor Education on Opioid Prescribing

July 11, 2017
FDA Chief Wants Doctor Education on Opioid Prescribing

FDA Commissioner Scott Gottlieb has proposed opioid drugmakers provide educational materials to doctors to more responsibly prescribe immediate-release opioids.